<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2023-368</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-7788</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>РЕПРОДУКТИВНОЕ ЗДОРОВЬЕ И ВРТ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REPRODUCTIVE HEALTH AND ART</subject></subj-group></article-categories><title-group><article-title>Поддержка врачебных решений с помощью глубокого машинного обучения при лечении бесплодия методами вспомогательных репродуктивных технологий</article-title><trans-title-group xml:lang="en"><trans-title>Deep machine learning applied to support clinical decision-making in the treatment of infertility using assisted reproductive technologies</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0545-1607</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>Ю. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>Ju. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Драпкина Юлия Сергеевна – кандидат медицинских наук, врач – акушер-гинеколог отделения вспомогательных технологий в лечении бесплодия имени профессора Б.В. Леонова.</p><p>117997, Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>Julia S. Drapkina - Cand. Sci. (Med.), Obstetrician-Gynecologist of the Department of Auxiliary Technologies in the Treatment of Infertility named after Professor B.V. Leonov, Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology.</p><p>4, Academician Oparin St., Moscow, 117997</p></bio><email xlink:type="simple">julia.drapkina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1396-7272</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макарова</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarova</surname><given-names>N. Р.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Макарова Наталья Петровна – доктор биологических наук, ведущий научный сотрудник, старший эмбриолог отделения вспомогательных технологий в лечении бесплодия имени профессора Б.В. Леонова.</p><p>117997, Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>Natalya Р. Makarova - Dr. Sci. (Biol.), Leading Researcher, Senior Embryologist of the Department of Auxiliary Technologies in the Treatment of Infertility named after Professor B.V. Leonov, Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology.</p><p>4, Academician Oparin St., Moscow, 117997</p></bio><email xlink:type="simple">n_makarova@oparina4.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-7998-7502</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Татаурова</surname><given-names>П. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Tataurova</surname><given-names>P. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татаурова Полина Дмитриевна – студент.</p><p>117997, Москва, ул. Островитянова, д. 1</p></bio><bio xml:lang="en"><p>Polina D. Tataurova - Student, Pirogov Russian National Research Medical University.</p><p>1, Ostrovityanov St., Moscow, 117997</p></bio><email xlink:type="simple">tataurovapd@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калинина</surname><given-names>Е. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalinina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Калинина Елена Анатольевна - доктор медицинских наук, профессор, заведующая отделением вспомогательных технологий в лечении бесплодия имени профессора Б.В. Леонова.</p><p>117997, Москва, ул. Академика Опарина, д. 4</p></bio><bio xml:lang="en"><p>Elena А. Kalinina - Dr. Sci. (Med.), Professor, Head of the Department of Auxiliary Technologies in the Treatment of Infertility named after Professor B.V. Leonov, Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology.</p><p>4, Academician Oparin St., Moscow, 117997</p></bio><email xlink:type="simple">e_kalinina@oparina4.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова<country>Россия</country></aff><aff xml:lang="en">Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Российский национальный исследовательский медицинский университет имени Н.И. Пирогова<country>Россия</country></aff><aff xml:lang="en">Pirogov Russian National Research Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>21</day><month>10</month><year>2023</year></pub-date><volume>0</volume><issue>15</issue><fpage>27</fpage><lpage>37</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Драпкина Ю.С., Макарова Н.П., Татаурова П.Д., Калинина Е.A., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Драпкина Ю.С., Макарова Н.П., Татаурова П.Д., Калинина Е.A.</copyright-holder><copyright-holder xml:lang="en">Drapkina J.S., Makarova N.Р., Tataurova P.D., Kalinina E.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/7788">https://www.med-sovet.pro/jour/article/view/7788</self-uri><abstract><sec><title>Введение</title><p>Введение. Анализ данных при помощи машинного обучения (МО) позволяет более точно и таргетно определить наиболее значимые корригируемые и некорригируемые предикторы наступления беременности в программах вспомогательных репродуктивных технологий (ВРТ) у пациенток разных возрастных групп. Анализ данных при помощи различных методов и сравнение результатов, полученных при использовании двух моделей, определит наиболее значимые факторы наступления беременности в программе ВРТ.</p></sec><sec><title>Цель исследования</title><p>Цель исследования. Определить наиболее значимые клинические и эмбриологические предикторы наступления беременности с использованием стандартного регрессионного анализа и алгоритма решающего дерева для прогнозирования наступления беременности в программе ВРТ.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В ретроспективное исследование была включена 1 021 супружеская пара. В исследовании были проанализированы данные клинико-лабораторных обследований и параметры стимулированного цикла в зависимости от эффективности программы ВРТ. Для определения наиболее значимых факторов был проведен регрессионный анализ и построен алгоритм решающего дерева с использованием критерия Джини.</p></sec><sec><title>Результаты</title><p>Результаты. Были выявлены «общие» признаки, которые требуют дальнейшей валидации на других моделях, в т. ч. с использованием МО: наличие/отсутствие беременностей в анамнезе, параметры стимулированного цикла (ОКК, количество ооцитов MII, количество зигот), показатели спермограммы в день пункции, количество эмбрионов отличного и хорошего качества, а также качество эмбриона.</p></sec><sec><title>Выводы</title><p>Выводы. Препарат рФСГ (фоллитропин-альфа, Гонал-ф) дает статистически значимый результат в двух из пяти доступных возрастных группах, фоллитропин-бета, корифоллитропин альфа – только в одной из пяти групп. Построение модели, включающей не только данные анамнеза супружеской пары, но и молекулярные маркеры с использованием методов машинного обучения позволит не только определить наиболее точно максимально перспективные группы пациентов для проведения программы ЭКО, но и повысить эффективность программ ВРТ за счет селекции максимально качественного эмбриона для переноса.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Machine learning (ML) applied to data analysis allows to more accurately and targetedly determine the most significant correctable and non-correctable predictors of onset of pregnancy in assisted reproductive technology (ART) programs in patients of different age groups. Analysis of data using various techniques and comparison of results obtained via two models will determine the most significant factors for onset of pregnancy in the ART program.</p></sec><sec><title>Aim</title><p>Aim. To determine the most significant clinical and embryological predictors of onset of pregnancy using standard regression analysis and a decision tree algorithm to predict pregnancy in the ART program.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A total of 1,021 married couples were included in the retrospective study. The study analysed clinical and laboratory test findings and stimulated cycle parameters depending on the effectiveness of the ART program. A regression analysis was carried out and a decision tree algorithm was built using the Gini criterion to determine the most significant factors.</p></sec><sec><title>Results</title><p>Results. We identified “general” signs that require further validation on other models, including ML: the presence/absence of a history of pregnancies, stimulated cycle parameters (oocyte cumulus complex, number of metaphase II (MII) oocytes, number of zygotes), spermogram indicators on the day of puncture, number of high and good quality embryos, as well as the embryo grading.</p></sec><sec><title>Conclusion</title><p>Conclusion. rFSH (follitropin-alpha, Gonal-f) gives a significant result in two of the five available age groups, follitropin-beta, corifollitropin alfa – in one of the five groups only. Building a model that includes not only the couple’s medical history data, but also molecular markers using machine learning methods will not only allow us to most accurately determine the most promising groups of patients for in vitro fertilization (IVF) programs, but also increase the efficiency of ART programs by selecting the highest quality embryo to be transferred.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>репродукция</kwd><kwd>ооциты</kwd><kwd>стимуляция овуляции</kwd><kwd>ЭКО</kwd><kwd>искусственный интеллект</kwd></kwd-group><kwd-group xml:lang="en"><kwd>reproduction</kwd><kwd>oocytes</kwd><kwd>ovulation stimulation</kwd><kwd>IVF</kwd><kwd>artificial intelligence</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Aristidou A, Jena R, Topol EJ. Bridging the chasm between AI and clinical implementation. Lancet. 2022;399(10325):620. https://doi.org/10.1016/S0140-6736(22)00235-5.</mixed-citation><mixed-citation xml:lang="en">Aristidou A, Jena R, Topol EJ. Bridging the chasm between AI and clinical implementation. Lancet. 2022;399(10325):620. https://doi.org/10.1016/S0140-6736(22)00235-5.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Barnett-Itzhaki Z, Elbaz M, Butterman R, Amar D, Amitay M, Racowsky C et al. Machine learning vs. classic statistics for the prediction of IVF out-comes. J Assist Reprod Genet. 2020;37(10):2405–2412. https://doi.org/10.1007/s10815-020-01908-1.</mixed-citation><mixed-citation xml:lang="en">Barnett-Itzhaki Z, Elbaz M, Butterman R, Amar D, Amitay M, Racowsky C et al. Machine learning vs. classic statistics for the prediction of IVF out-comes. J Assist Reprod Genet. 2020;37(10):2405–2412. https://doi.org/10.1007/s10815-020-01908-1.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Yu SH, Wang HL. An Updated Decision Tree for Horizontal Ridge Augmentation: A Narrative Review. Int J Periodontics Restorative Dent. 2022;42(3):341–349. https://doi.org/10.11607/prd.5031.</mixed-citation><mixed-citation xml:lang="en">Yu SH, Wang HL. An Updated Decision Tree for Horizontal Ridge Augmentation: A Narrative Review. Int J Periodontics Restorative Dent. 2022;42(3):341–349. https://doi.org/10.11607/prd.5031.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Carugo O. Hydrophobicity diversity in globular and nonglobular proteins measured with the Gini index. Protein Eng Des Sel. 2017;30(12):781–784. https://doi.org/10.1093/protein/gzx060.</mixed-citation><mixed-citation xml:lang="en">Carugo O. Hydrophobicity diversity in globular and nonglobular proteins measured with the Gini index. Protein Eng Des Sel. 2017;30(12):781–784. https://doi.org/10.1093/protein/gzx060.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Amisha, Malik P, Pathania M, Rathaur VK. Overview of artificial intelligence in medicine. J Family Med Prim Care. 2019;8(7):2328–2331. https://doi.org/10.4103/jfmpc.jfmpc_440_19.</mixed-citation><mixed-citation xml:lang="en">Amisha, Malik P, Pathania M, Rathaur VK. Overview of artificial intelligence in medicine. J Family Med Prim Care. 2019;8(7):2328–2331. https://doi.org/10.4103/jfmpc.jfmpc_440_19.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zaninovic N, Rosenwaks Z. Artificial intelligence in human in vitro fertilization and embryology. Fertil Steril. 2020;114(5):914–920. https://doi.org/10.1016/j.fertnstert.2020.09.157.</mixed-citation><mixed-citation xml:lang="en">Zaninovic N, Rosenwaks Z. Artificial intelligence in human in vitro fertilization and embryology. Fertil Steril. 2020;114(5):914–920. https://doi.org/10.1016/j.fertnstert.2020.09.157.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Xu T, de Figueiredo Veiga A, Hammer KC, Paschalidis IC, Mahalingaiah S. Informative predictors of pregnancy after first IVF cycle using eIVF practice highway electronic health records. Sci Rep. 2022;12(1):839. https://doi.org/10.1038/s41598-022-04814-x.</mixed-citation><mixed-citation xml:lang="en">Xu T, de Figueiredo Veiga A, Hammer KC, Paschalidis IC, Mahalingaiah S. Informative predictors of pregnancy after first IVF cycle using eIVF practice highway electronic health records. Sci Rep. 2022;12(1):839. https://doi.org/10.1038/s41598-022-04814-x.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Orvieto R. Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF. Reprod Biol Endocrinol. 2023;21(1):13. https://doi.org/10.1186/s12958-023-01069-7.</mixed-citation><mixed-citation xml:lang="en">Orvieto R. Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF. Reprod Biol Endocrinol. 2023;21(1):13. https://doi.org/10.1186/s12958-023-01069-7.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Vaegter KK, Lakic TG, Olovsson M, Berglund L, Brodin T, Holte J. Which factors are most predictive for live birth after in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) treatments? Analysis of 100 prospectively recorded variables in 8,400 IVF/ICSI single-embryo transfers. Fertil Steril. 2017;107(3):641–648.e2. https://doi.org/10.1016/j.fertnstert.2016.12.005.</mixed-citation><mixed-citation xml:lang="en">Vaegter KK, Lakic TG, Olovsson M, Berglund L, Brodin T, Holte J. Which factors are most predictive for live birth after in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) treatments? Analysis of 100 prospectively recorded variables in 8,400 IVF/ICSI single-embryo transfers. Fertil Steril. 2017;107(3):641–648.e2. https://doi.org/10.1016/j.fertnstert.2016.12.005.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Orvieto R, Kirshenbaum M, Galiano V, Zilberberg E, Haas J, Nahum R. Stop GnRH-Agonist Combined with Multiple-Dose GnRH-Antagonist for Patients with Elevated Peak Serum Progesterone Levels Undergoing Ovarian Stimulation for IVF: A Proof of Concept. Gynecol Obstet Invest. 2020;85(4):357–361. https://doi.org/10.1159/000508875.</mixed-citation><mixed-citation xml:lang="en">Orvieto R, Kirshenbaum M, Galiano V, Zilberberg E, Haas J, Nahum R. Stop GnRH-Agonist Combined with Multiple-Dose GnRH-Antagonist for Patients with Elevated Peak Serum Progesterone Levels Undergoing Ovarian Stimulation for IVF: A Proof of Concept. Gynecol Obstet Invest. 2020;85(4):357–361. https://doi.org/10.1159/000508875.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lensen SF, Wilkinson J, Leijdekkers JA, La Marca A, Mol BWJ, Marjoribanks J et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Cochrane Database Syst Rev. 2018;2(2):CD012693. https://doi.org/10.1002/14651858.CD012693.pub2.</mixed-citation><mixed-citation xml:lang="en">Lensen SF, Wilkinson J, Leijdekkers JA, La Marca A, Mol BWJ, Marjoribanks J et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Cochrane Database Syst Rev. 2018;2(2):CD012693. https://doi.org/10.1002/14651858.CD012693.pub2.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bedenk J, Vrtačnik-Bokal E, Virant-Klun I. The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility. J Assist Reprod Genet. 2020;37(1):89–100. https://doi.org/10.1007/s10815-019-01622-7.</mixed-citation><mixed-citation xml:lang="en">Bedenk J, Vrtačnik-Bokal E, Virant-Klun I. The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility. J Assist Reprod Genet. 2020;37(1):89–100. https://doi.org/10.1007/s10815-019-01622-7.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nelson SM, Fleming R, Gaudoin M, Choi B, Santo-Domingo K, Yao M. Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth. Fertil Steril. 2015;104(2):325–332. https://doi.org/10.1016/j.fertnstert.2015.04.032.</mixed-citation><mixed-citation xml:lang="en">Nelson SM, Fleming R, Gaudoin M, Choi B, Santo-Domingo K, Yao M. Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth. Fertil Steril. 2015;104(2):325–332. https://doi.org/10.1016/j.fertnstert.2015.04.032.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Pilsgaard F, Grynnerup AG, Løssl K, Bungum L, Pinborg A. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling. Acta Obstet Gynecol Scand. 2018;97(9):1105–1113. https://doi.org/10.1111/aogs.13334.</mixed-citation><mixed-citation xml:lang="en">Pilsgaard F, Grynnerup AG, Løssl K, Bungum L, Pinborg A. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling. Acta Obstet Gynecol Scand. 2018;97(9):1105–1113. https://doi.org/10.1111/aogs.13334.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wang R, Pan W, Jin L, Li Y, Geng Y, Gao C et al. Artificial intelligence in reproductive medicine. Reproduction. 2019;158(4):R139–R154. https://doi.org/10.1530/REP-18-0523.</mixed-citation><mixed-citation xml:lang="en">Wang R, Pan W, Jin L, Li Y, Geng Y, Gao C et al. Artificial intelligence in reproductive medicine. Reproduction. 2019;158(4):R139–R154. https://doi.org/10.1530/REP-18-0523.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Сыркашева АГ, Ибрагимова ЭО. Применение комбинированного препарата рекомбинантного фолликулостимулирующего гормона/лютеинизирующего гормона в программах вспомогательных репродуктивных технологий. Медицинский совет. 2016;(12):74–78. https://doi.org/10.21518/2079-701X-2016-12-74-78.</mixed-citation><mixed-citation xml:lang="en">Syrkasheva AG, Ibragimova EO. Application of combined drug of recombinant follicule-stimulating hormone/luteinizing hormone in programs of assisted reproductive technologies. Meditsinskiy Sovet. 2016;(12):74–78. (In Russ.) https://doi.org/10.21518/2079-701X-2016-12-74-78.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hugues JN. Impact of ‘LH activity’ supplementation on serum progesterone levels during controlled ovarian stimulation: a systematic review. Hum Reprod. 2012;27(1):232–243. https://doi.org/10.1093/humrep/der380.</mixed-citation><mixed-citation xml:lang="en">Hugues JN. Impact of ‘LH activity’ supplementation on serum progesterone levels during controlled ovarian stimulation: a systematic review. Hum Reprod. 2012;27(1):232–243. https://doi.org/10.1093/humrep/der380.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Виноградова ЛВ, Мишиева НГ, Абубакиров АН, Левков ЛА, Мартынова МВ. Гормональные особенности циклов ЭКО, стимулированных человеческим менопаузальным гонадотропином и рекомбинатным ФСГ в протоколах с антагонистом гонадотропин-рилизинг гормона. Акушерство и гинекология. 2014;(11):88–95. Режим доступа: https://ru.aig-journal.ru/articles/Gormonalnye-osobennosti-ciklov-EKO-stimulirovannyh-chelovecheskim-menopauzalnym-gonadotropinom-i-rekombinatnym-FSG-v-protokolah-s-antagonistom-gonadot.html?ysclid=lnmyih8y29257675120.</mixed-citation><mixed-citation xml:lang="en">Vinogradova LV, Mishieva NG, Abubakirov AN, Levkov LA, Martynova MV. Hormonal features of IVF cycles stimulated with human menopausal gonadotropin and recombinant follicle-stimulating hormone in gonadotropin-releasing hormone antagonist protocols. Akusherstvo i Ginekologiya (Russian Federation). 2014;(11):88–95. (In Russ.) Available at: https://ru.aig-journal.ru/articles/Gormonalnye-osobennosti-ciklov-EKO-stimulirovannyh-chelovecheskim-menopauzalnym-gonadotropinom-i-rekombinatnym-FSG-v-protokolah-s-antagonistom-gonadot.html?ysclid=lnmyih8y29257675120.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang Y, Wang L, Shen H, Wang B, Wu J, Hu K et al. The effect of progesterone supplementation for luteal phase support in natural cycle frozen embryo transfer: a systematic review and meta-analysis based on randomized controlled trials. Fertil Steril. 2023;119(4):597–605. https://doi.org/10.1016/j.fertnstert.2022.12.035.</mixed-citation><mixed-citation xml:lang="en">Jiang Y, Wang L, Shen H, Wang B, Wu J, Hu K et al. The effect of progesterone supplementation for luteal phase support in natural cycle frozen embryo transfer: a systematic review and meta-analysis based on randomized controlled trials. Fertil Steril. 2023;119(4):597–605. https://doi.org/10.1016/j.fertnstert.2022.12.035.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Alyasin A, Mehdinejadiani S, Ghasemi M. GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article. Int J Reprod Biomed. 2016;14(9):557–566. Available at: https://pubmed.ncbi.nlm.nih.gov/27738657.</mixed-citation><mixed-citation xml:lang="en">Alyasin A, Mehdinejadiani S, Ghasemi M. GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article. Int J Reprod Biomed. 2016;14(9):557–566. Available at: https://pubmed.ncbi.nlm.nih.gov/27738657.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
